Alzamend Neuro, INC. (ALZN) — S-1/A Filings
All S-1/A filings from Alzamend Neuro, INC.. Browse 3 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (3)
-
Alzamend Neuro Files S-1/A Amendment
— Mar 27, 2025 Risk: medium
Alzamend Neuro, Inc. filed an S-1/A amendment on March 27, 2025, for its registration statement. The company, incorporated in Delaware, is in the pharmaceutical -
Alzamend Neuro Files S-1/A Amendment
— Jul 3, 2024 Risk: medium
Alzamend Neuro, Inc. filed an S-1/A amendment on July 3, 2024, to its registration statement. The company, incorporated in Delaware, is in the pharmaceutical pr -
Alzamend Neuro Files S-1/A Amendment
— Jun 26, 2024 Risk: medium
Alzamend Neuro, Inc. filed an amendment (S-1/A) on June 26, 2024, to its registration statement. The company, incorporated in Delaware, is in the pharmaceutical
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX